Physician profile
Marc E Musson
NPI 1649589896
$824.44
in general payments reported to CMS, 2019-2025
10 companies · $590 in 2025
The $590 reported for 2025 was more than what 81% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.10 · 2024: $220 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $301.88 | 2024-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $246.61 | 2024-2025 | General - Pain Management, Intracept |
| Abbvie INC. | $75.24 | 2025 | |
| Tersera Therapeutics LLC | $49.40 | 2025 | Prialt |
| Pfizer INC. | $36.89 | 2019-2025 | |
| Nevro Corp. | $34.20 | 2024 | Senza |
| Medtronic, INC. | $23.33 | 2025 | Synchromedii |
| Vertex Pharmaceuticals Incorporated | $20.19 | 2025 | |
| Saluda Medical Americas, INC. | $20.04 | 2025 | Evoke |
| Abbott Laboratories | $16.66 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Musson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.